What are the available packaging sizes?

The product is available in 250ml/bottle, 500ml/bottle, and 1L/bottle.

Is OEM or ODM service available?

Yes, both OEM and ODM services are available for this product.

What is the lead time for orders?

The average lead time is one month for both peak and off-peak seasons.

Veterinary Medicine Anti-Virus Herbal Solution Animal Drug Product

Name: Veterinary Medicine Anti-Virus Herbal Solution Animal Drug Product
Brand: Henan Muxiang Biological Co., Ltd.
SKU: 1949844372

Henan, ChinaHenan Muxiang Biological Co., Ltd.

US$1.69

1,000 Pieces

Product profile

Customization

Available

Varieties

Growth Promoting Medicine

Component

Herbal

Model NO.

250ml/bottle; 1L/bottle

Type

The First Class

Pharmacodynamic Influential Factors

Combined Medication

Storage Method

Light Proof

Transport Package

Carton

Specification

250ml/bottle

Trademark

MOOSUN

Origin

China

HS Code

3004909090

Production Capacity

50000pieces/Month

Key features

Patented Technology: Holds a Patent Certificate for the unique preparation technology.

High Absorption Rate: Active ingredients absorption rate is 30% higher than traditional technology.

Effective Viral Treatment: Prevents and treats Newcastle, Influenza, and Duck paramyxovirus with lasting efficacy.

Pure Herbal Formula: Natural herbal product with no residue and no drug resistance.

Symptom Relief: Effectively eliminates respiratory symptoms like cough and snoring.

Intestinal Repair: Repairs intestinal mucosa and effectively treats green manure issues.

No Withdrawal Period: Safe for use with no required withdrawal period before consumption.

Customizable Packaging: Available in 250ml, 500ml, and 1L bottle sizes.

Company profile

Henan Muxiang Biological Co., Ltd.

Henan, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2016-02-01 CertifiedNearest Port: Shanghai Port, Qingdao PortAverage Response Time: ≤11.20h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryHenan Muxiang Biological Co., Ltd. is a China-based limited-company factory established in 2004, with 360 employees and operations in veterinary pharmaceuticals and animal-health products. The supplier reports seven pharmaceutical production lines, eight vaccine production lines, first-class production and inspection equipment, GMP management, ISO9001:2015 certification, and ISO/CNAS laboratory certification. Its R&D resources include more than 40 core personnel, over 30 of whom hold doctoral or master's degrees, while 21–30 quality-control staff are reported. The company exports to multiple global regions, has self-operated import and export rights, and states a one-month order-fulfillment period in both peak and off-peak seasons. Evidence supports capabilities in certification, innovation, production, and international operations. However, the provided information does not sufficiently establish after-sales service performance, financial credibility, customization execution, or specific customer cases.

Supplier typeThe supplier is identified as a limited company and a factory in the manufacturing industry, with its operating location in Henan, China. This indicates a direct manufacturing entity rather than only a trading or intermediary business.

CertificationsThe supplier reports a systematic GMP management system, ISO/CNAS laboratory international certification, and an ISO9001:2015 certificate. These stated certifications and quality systems provide explicit evidence of formal quality-management capability.

R&D capabilityThe supplier reports more than 40 core R&D personnel, including over 30 doctors or master's degree graduates, 20 years of preparation-technology experience among R&D engineers, and advanced R&D platforms such as a National Enterprise Technology Center, National Postdoctoral Research Station, and Academician Workstation. It also reports improving herbal active-ingredient extraction by more than 30% versus a traditional process, supporting a strong stated innovation profile.

Production capacityThe supplier reports seven pharmaceutical production lines and eight vaccine production lines, first-class production and inspection equipment, six production lines in a separate operational data field, and one-month order fulfillment in both peak and off-peak seasons. Although the line-count figures are not fully consistent across the slices, the evidence clearly supports substantial pharmaceutical and vaccine manufacturing capability.